Your IOL Claim Is Clear. What Did the Patient Hear?

Illustrative stock photograph, not a PDDA® client team. Photo: Tima Miroshnichenko / Pexels.

The product team has a clear message. The sales team knows it. The surgeon understands the technology.

Then somebody asks the patient: “What do you expect this lens to change in your life?”

The answer describes a different promise.

That gap deserves its own investigation. A polished presentation tells you what the company said. It does not tell you what survived the journey to the patient.

One phrase. Several possible meanings.

Take a hypothetical phrase: “less dependence on glasses.” This is an illustrative communication example, not a claim for a particular IOL.

A professional may read that phrase as a qualified benefit, with a specific evidence base and limitations to discuss. A patient might hear “no glasses for anything.” Another might care only about reading messages. A third might want fewer changes between pairs of glasses at work.

Those are different expectations. Repeating the phrase more confidently will not tell you which one the person has formed.

Nor should you assume that every refusal reflects a misunderstanding. Price can be the real constraint. Clinical suitability, personal preferences and a considered decision to keep wearing glasses can all be legitimate reasons to choose something else.

The useful question is narrower: did this patient understand the relevant option well enough to make their own choice?

Follow the claim, not the slide deck

Choose one message that matters commercially. Follow it through the material and conversations a patient actually encounters:

1. Product claim. What does the approved wording say, for this product and market? What qualifications belong with it?
2. Clinic promise. How does the website, booking team or education material express it?
3. Consultation. How does the team connect it to this person's priorities and the clinician's assessment?
4. Patient meaning. In the patient's own words, what benefit do they expect, and what limitation do they understand?
5. Next step. Who addresses the remaining question, and does that question reach them?

Put those five versions next to one another. You now have something more useful than “the team needs better communication”: an observable place where meaning may have changed.

Sometimes the wording is the problem. Sometimes an important qualification disappeared during a handoff. Sometimes everybody gave an accurate explanation, but nobody asked what the patient was trying to achieve.

A small working artifact beats another abstract framework

I would start with a one-page claim-to-patient map: the original wording, the clinic's wording, the patient's interpretation, the unresolved question and the person responsible for addressing it.

For example, a patient says: “I expect never to need glasses.” The map should not turn that into a sales objection to overcome. It should flag an expectation for the clinician to clarify against the actual options and their limitations.

Ask a neutral question such as: “How would you explain what this option might help with—and what it might not solve?” It is a check on the explanation, not an exam the patient has to pass.

Use only appropriately authorised, consented or anonymised material. Begin with a small, consecutive sample from the real pathway, not just the clinic's success stories. This is an exploratory workflow check, not a validated clinical instrument or a study proving effectiveness.

Different finding. Different project.

If the gap starts in a local-language description, the project may be a patient-language review and test. If it starts between the counsellor and surgeon, it may be a handoff redesign. If the revised process is understood but not used, it is an implementation problem: ownership, prompts in the workflow, practice and feedback.

If patients understand the option and still decline because of cost or preferences, another wording exercise may be the wrong investment.

This matters for an IOL company. A clinic pilot should help the sponsor decide what to change, what is worth scaling and what should stop. A favourable response to a workshop is not that decision.

What I would measure

First, whether the intended workflow happened: was the priority captured, was the unresolved question handed over, and was understanding checked?

Then look separately at the time required, documented offering to clinically suitable patients, acceptance among those appropriately offered an option, and any expectation problems identified. Define the denominators before comparing results. Record changes in staffing, prices or patient mix that could also explain a difference.

A small before-and-after pilot can inform the next operating decision. It cannot, on its own, prove that one intervention caused a change in adoption.

Where PDDA® comes in

Within PDDA®, Smart Values helps structure what matters to the patient, Smart Promise examines how a promise becomes an expectation, and Smart Sight structures the decision conversation. Easy Lens Selector can support preparation; it does not replace clinical assessment or the rest of the pathway.

The names are useful internally. The client should receive something concrete: a diagnosed gap, usable changes to the pathway, clear team ownership and a plan for checking what happened.

You may already have a strong agency and an excellent trainer. Keep them. Bring this question into the same room: where, exactly, does the meaning of our product change before the patient makes a decision?

That is the work I do with IOL companies and cataract/RLE clinics.

Explore IOL brand advisory or discuss a specific patient-decision gap.

This article describes a proposed diagnostic approach and illustrative scenarios. It reports no client results and makes no claim that a particular lens or intervention is suitable for an individual patient.